There is a good chance that the Federal Trade Commission’s recent reversal of a decision by an administrative law judge on LabMD’s data security practices will be appealed in court, according to attorneys familiar with the field. But in the meantime, and especially if the appeal is not successful, companies appearing before the FTC will likely have a higher bar to pass to prove data security.

The case centers around how LabMD, a clinical lab for physicians, allegedly failed to protect medical and other personal information of consumers. Between 2001 and 2014, LabMD collected sensitive personal information on over 750,000 patients.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]